Evidence map›Paper›PMID 40564039›Full record

ArticleBiomedicines2025

Targeting RPLP2 Triggers DLBCL Ferroptosis by Decreasing FXN Expression.

Jiaxing Guo, Bokang Yan, Lingshu Li, Yuanhao Peng, Weiwei Lai, Chanjuan Shen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiaxing GuoDepartment of Hematology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou 412007, China.
Bokang YanDepartment of Pathology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou 412007, China.
Lingshu LiDepartment of Hematology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou 412007, China.
Yuanhao PengNHC Key Laboratory of Carcinogenesis, Central South University, Changsha 410078, China.
Weiwei LaiHunan Provincial Key Laboratory of Pediatric Orthopedics, The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University, Changsha 410007, China.
Chanjuan ShenDepartment of Hematology, Zhuzhou Hospital Affiliated to Xiangya School of Medicine, Central South University, Zhuzhou 412007, China.

Funding

National Key Research and Development Program of China 2023YFC2507605Opening fundings of Hunan Provincial Key Laboratory of Pediatric Orthopedics 2023TP1019Provincial and Municipal Joint Fund of the Natural Science Foundation of Hunan Province, China 2020JJ6109
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Destruxin bDLBCLdoxorubicinferroptosisFXNRPLP2

Identifiers

PMID40564039
PMCPMC12189634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.